Benchmark

According to a research report published this morning, Benchmark has lowered Big Lots' (NYSE: BIG) PT from $50 to $45. In the report, Benchmark said, "Big Lots' Q1 EPS was $0.68, versus our and consensus estimate of $0.69, after the Company pre-announced a weakness in comps. While we maintained...

According to a research report published this morning, Benchmark has lowered McGraw-Hill Companies' (NYSE: MHP) PT from $52 to $50. In the report, Benchmark said, "US and Euro denominated investment grade and high yield bond issuance has slowed materially in recent weeks, based on industry...

According to a research report published this morning, Benchmark has lowered American Science & Engineering's (NASDAQ: ASEI) PT from $66 to $58. Benchmark mentioned in the report, "AS&E reported Q4FY12 revenue and EPS of $39.8 million, down 41% y/y, and $0.15, significantly lower than...

According to a research report published this morning, Benchmark has lowered Groupon's (NASDAQ: GRPN) PT from $28 to $20. Benchmark said in the report, "Groupon reported 1Q12 results and 2Q12 guidance that topped expectations. Operating metrics showed no sign of competitive pressure, with a 41%...

According to a research report published this morning, Benchmark has increased Vitacost.com's (NASDAQ: VITC) PT from $7 to $8. Benchmark commented, "Vitacost (VITC-Hold, PT from $7 to $8) reported better than expected revenue of $83.6 million, up 31% y/y, well ahead of consensus at $76.3 million...

According to a research report published this morning, Benchmark has upgraded The E.W. Scripps Company (NYSE: SSP) from Hold to Buy, and raised PT from $10.50 to $11. Benchmark said in the report, "We are upgrading E.W.Scripps (SSP) from Hold to Buy and raising our target price from $10.50 to $11...

According to a research report published this morning, Benchmark has initiated Smith & Wesson (NASDAQ: SWHC) with a Buy rating and $9 PT. In the report, Benchmark said, "Our price target is based on an 8.5x FY13 EV/EBITDA multiple, which we believe is appropriate for an industry leader well...

According to a research report published this morning, Benchmark has initiated Sturm, Ruger & Company (NYSE: RGR) with a Buy rating and $60 PT. In the report, Benchmark commented, "Our price target is based on a 10x FY12 EV/EBITDA multiple, which we believe is appropriate for an industry...

Following a massive ~40% drop in shares after market close yesterday, it may be surprising to some that Fossil (NASDAQ: FOSL) has climbed back up, trading +1% for the day thus far. With controversy buzzing around the stock's weak European numbers and a pending acquisition, it appears that this...

According to a research report published this morning, Benchmark has initiated Vascular Solutions (NASDAQ: VASC) with a Buy rating and $15 PT. In the report, Benchmark said, "We are initiating coverage of Vascular Solutions (VASC) with a Buy rating and a twelve month price target of $15.00. Our $...